Clinical characteristics of COPD syndrome: A 6-year follow-up study of adult smokers

References

• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). The global strategy for the diagnosis, management and prevention of COPD. 2011. Available at: http://www.goldcopd.org (accessed 30 May 2012).
   Google Scholar
• Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183:1129–37.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Calle M, Soler-Cataluna JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48:86–98.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.
   PubMed Web of Science ®Google Scholar
• Johannessen A, Nilsen RM, Storebo M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. 2013;188:51–9.
   PubMed Web of Science ®Google Scholar
• Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186:975–81.
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Mullerova H, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 2013;42:636–46.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest. 2013;143:694–702.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sanchez G, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107:1053–60.
   Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245–57.
   PubMed Web of Science ®Google Scholar
• Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med. 2010;182:325–31.
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186:155–61.
   PubMed Web of Science ®Google Scholar
• Han MK, Muellerova H, Curran-Everett D, Dransfield MT, Washko GR, Regan EA, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1:43–50.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Soriano JB, Miravitlles M, Munoz L, Duran-Tauleria E, Sanchez G, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9:e105220.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Huerta A, Fernandez-Villar J, Alcazar B, Villa G, Forne C, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014;12:120.
   PubMed Web of Science ®Google Scholar
• Toljamo T, Kaukonen M, Nieminen P, Kinnula VL. Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scand J Prim Health Care. 2010;28: 41–6.
   PubMed Web of Science ®Google Scholar
• Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184:57–63.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–6.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–54.
   PubMed Web of Science ®Google Scholar
• Jones PW. COPD assessment test—rationale, development, validation and performance. COPD. 2013;10:269–71.
   PubMedGoogle Scholar
• Sovijärvi A, Ahonen A, Hartiala J, L nsimies E, Savolainen S, Turjanmaa V, et al., editors. Kliinisen fysiologian perusteet. 1st ed. Otavan Kirjapaino Oy, Keuruu, Finland: Duodecim; 2012. [Finnish]
   Google Scholar
• Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest. 2006;130:1129–37.
   PubMed Web of Science ®Google Scholar
• Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Curr Opin Pulm Med. 2008;14:105–9.
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res. 2005;6:98.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153:1530–5.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2002;166:329–32.
   PubMed Web of Science ®Google Scholar
• de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175:32–9.
   PubMed Web of Science ®Google Scholar
• Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182:598–604.
   PubMed Web of Science ®Google Scholar
• Kim V, Sternberg AL, Washko G, Make BJ, Han MK, Martinez F, et al. Severe chronic bronchitis in advanced emphysema increases mortality and hospitalizations. COPD. 2013;10:667–78.
   PubMedGoogle Scholar
• Renom F, Yanez A, Garau M, Rubi M, Centeno MJ, Gorriz MT, et al. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection. Respir Med. 2010;104:840–8.
   PubMed Web of Science ®Google Scholar
• Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis. 2006;1:91–6.
   PubMedGoogle Scholar
• Mannino DM, Diaz-Guzman E, Pospisil J. A new approach to classification of disease severity and progression of COPD. Chest. 2013;144:1179–85.
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Kocks JW, Stone IS, Breyer-Kohansal R, Greulich T, Lacedonia D, et al. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? Thorax. 2014;69:72–9.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med. 2014;189:1022–30.
   PubMed Web of Science ®Google Scholar
• Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44:341–50.
   PubMed Web of Science ®Google Scholar
• Braman SS. The chronic obstructive pulmonary disease-asthma overlap syndrome. Allergy Asthma Proc. 2015;36:11–18.
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention, global initiative for asthma (GINA) 2014. Available at: http://www.ginasthma.org/ (accessed 6 March 2015).
   Google Scholar
• Kankaanranta H, Harju T, Kilpelainen M, Mazur W, Lehto JT, Katajisto M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116:291–307.
   PubMed Web of Science ®Google Scholar
• Cerveri I, Corsico AG, Grosso A, Albicini F, Ronzoni V, Tripon B, et al. The rapid FEV(1) decline in chronic obstructive pulmonary disease is associated with predominant emphysema: a longitudinal study. COPD. 2013;10:55–61.
   PubMedGoogle Scholar
• Stratelis G, Fransson SG, Schmekel B, Jakobsson P, Molstad S. High prevalence of emphysema and its association with BMI: a study of smokers with normal spirometry. Scand J Prim Health Care. 2008; 26:241–7.
   PubMed Web of Science ®Google Scholar
• Xie X, Dijkstra AE, Vonk JM, Oudkerk M, Vliegenthart R, Groen HJ. Chronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CT. AJR Am J Roentgenol. 2014; 203:W383–90.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
   PubMed Web of Science ®Google Scholar